Pharmacogenomics of maternal tobacco use: Metabolic gene polymorphisms and risk of adverse pregnancy outcomes

Kjersti Aagaard-Tillery, Catherine Y. Spong, Elizabeth Thom, Baha Sibai, George Wendel, Katharine Wenstrom, Philip Samuels, Hyagriv Simhan, Yoram Sorokin, Menachem Miodovnik, Paul Meis, Mary J. O'Sullivan, Deborah Conway, Ronald J. Wapner

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective: To assess whether functional maternal or fetal genotypes along well-characterized metabolic pathways (ie, CYP1A1, GSTT1, and CYP2A6) may account for varying associations with adverse outcomes among pregnant women who smoke. Methods: DNA samples from 502 smokers and their conceptuses, alongside women in a control group, were genotyped for known functional allelic variants of CYP1A1 (Ile462Val AA>AG/GG), GSTT1(del), and CYP2A6 (Lys160His T>A). Modification of the association between smoking and outcome by genotype was evaluated. Outcomes included birth weight, pregnancy loss, preterm birth, small for gestational age, and a composite outcome composed of the latter four components plus abruption. Results: No interaction between maternal or fetal genotype of any of the polymorphisms and smoking could be demonstrated. In contrast, the association of smoking with gestational age-adjusted birth weight (birth weight ratio) was modified by fetal GSTT1 genotype (P for interaction=.02). Fetuses with GSTT1(del) had a mean birth weight reduction among smokers of 262 g (P=.01), whereas in fetuses without the GSTT1(del) the effect of tobacco exposure was nonsignificant (mean reduction 87 g, P=.16). After adjusting for confounding, results were similar. Conclusion: Fetal GSTT1 deletion significantly and specifically modifies the effect of smoking on gestational age-corrected birth weight.

Original languageEnglish (US)
Pages (from-to)568-577
Number of pages10
JournalObstetrics and gynecology
Volume115
Issue number3
DOIs
StatePublished - Mar 1 2010
Externally publishedYes

Fingerprint

Pharmacogenetics
Tobacco Use
Pregnancy Outcome
Birth Weight
Mothers
Smoking
Genotype
Gestational Age
Cytochrome P-450 CYP1A1
Genes
Weight Loss
Fetus
Premature Birth
Metabolic Networks and Pathways
Smoke
Tobacco
Pregnant Women
Pregnancy
Control Groups
DNA

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Pharmacogenomics of maternal tobacco use : Metabolic gene polymorphisms and risk of adverse pregnancy outcomes. / Aagaard-Tillery, Kjersti; Spong, Catherine Y.; Thom, Elizabeth; Sibai, Baha; Wendel, George; Wenstrom, Katharine; Samuels, Philip; Simhan, Hyagriv; Sorokin, Yoram; Miodovnik, Menachem; Meis, Paul; O'Sullivan, Mary J.; Conway, Deborah; Wapner, Ronald J.

In: Obstetrics and gynecology, Vol. 115, No. 3, 01.03.2010, p. 568-577.

Research output: Contribution to journalArticle

Aagaard-Tillery, K, Spong, CY, Thom, E, Sibai, B, Wendel, G, Wenstrom, K, Samuels, P, Simhan, H, Sorokin, Y, Miodovnik, M, Meis, P, O'Sullivan, MJ, Conway, D & Wapner, RJ 2010, 'Pharmacogenomics of maternal tobacco use: Metabolic gene polymorphisms and risk of adverse pregnancy outcomes', Obstetrics and gynecology, vol. 115, no. 3, pp. 568-577. https://doi.org/10.1097/AOG.0b013e3181d06faf
Aagaard-Tillery, Kjersti ; Spong, Catherine Y. ; Thom, Elizabeth ; Sibai, Baha ; Wendel, George ; Wenstrom, Katharine ; Samuels, Philip ; Simhan, Hyagriv ; Sorokin, Yoram ; Miodovnik, Menachem ; Meis, Paul ; O'Sullivan, Mary J. ; Conway, Deborah ; Wapner, Ronald J. / Pharmacogenomics of maternal tobacco use : Metabolic gene polymorphisms and risk of adverse pregnancy outcomes. In: Obstetrics and gynecology. 2010 ; Vol. 115, No. 3. pp. 568-577.
@article{10ebc16341ac4431ba2ac66b9f83eae5,
title = "Pharmacogenomics of maternal tobacco use: Metabolic gene polymorphisms and risk of adverse pregnancy outcomes",
abstract = "Objective: To assess whether functional maternal or fetal genotypes along well-characterized metabolic pathways (ie, CYP1A1, GSTT1, and CYP2A6) may account for varying associations with adverse outcomes among pregnant women who smoke. Methods: DNA samples from 502 smokers and their conceptuses, alongside women in a control group, were genotyped for known functional allelic variants of CYP1A1 (Ile462Val AA>AG/GG), GSTT1(del), and CYP2A6 (Lys160His T>A). Modification of the association between smoking and outcome by genotype was evaluated. Outcomes included birth weight, pregnancy loss, preterm birth, small for gestational age, and a composite outcome composed of the latter four components plus abruption. Results: No interaction between maternal or fetal genotype of any of the polymorphisms and smoking could be demonstrated. In contrast, the association of smoking with gestational age-adjusted birth weight (birth weight ratio) was modified by fetal GSTT1 genotype (P for interaction=.02). Fetuses with GSTT1(del) had a mean birth weight reduction among smokers of 262 g (P=.01), whereas in fetuses without the GSTT1(del) the effect of tobacco exposure was nonsignificant (mean reduction 87 g, P=.16). After adjusting for confounding, results were similar. Conclusion: Fetal GSTT1 deletion significantly and specifically modifies the effect of smoking on gestational age-corrected birth weight.",
author = "Kjersti Aagaard-Tillery and Spong, {Catherine Y.} and Elizabeth Thom and Baha Sibai and George Wendel and Katharine Wenstrom and Philip Samuels and Hyagriv Simhan and Yoram Sorokin and Menachem Miodovnik and Paul Meis and O'Sullivan, {Mary J.} and Deborah Conway and Wapner, {Ronald J.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1097/AOG.0b013e3181d06faf",
language = "English (US)",
volume = "115",
pages = "568--577",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Pharmacogenomics of maternal tobacco use

T2 - Metabolic gene polymorphisms and risk of adverse pregnancy outcomes

AU - Aagaard-Tillery, Kjersti

AU - Spong, Catherine Y.

AU - Thom, Elizabeth

AU - Sibai, Baha

AU - Wendel, George

AU - Wenstrom, Katharine

AU - Samuels, Philip

AU - Simhan, Hyagriv

AU - Sorokin, Yoram

AU - Miodovnik, Menachem

AU - Meis, Paul

AU - O'Sullivan, Mary J.

AU - Conway, Deborah

AU - Wapner, Ronald J.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Objective: To assess whether functional maternal or fetal genotypes along well-characterized metabolic pathways (ie, CYP1A1, GSTT1, and CYP2A6) may account for varying associations with adverse outcomes among pregnant women who smoke. Methods: DNA samples from 502 smokers and their conceptuses, alongside women in a control group, were genotyped for known functional allelic variants of CYP1A1 (Ile462Val AA>AG/GG), GSTT1(del), and CYP2A6 (Lys160His T>A). Modification of the association between smoking and outcome by genotype was evaluated. Outcomes included birth weight, pregnancy loss, preterm birth, small for gestational age, and a composite outcome composed of the latter four components plus abruption. Results: No interaction between maternal or fetal genotype of any of the polymorphisms and smoking could be demonstrated. In contrast, the association of smoking with gestational age-adjusted birth weight (birth weight ratio) was modified by fetal GSTT1 genotype (P for interaction=.02). Fetuses with GSTT1(del) had a mean birth weight reduction among smokers of 262 g (P=.01), whereas in fetuses without the GSTT1(del) the effect of tobacco exposure was nonsignificant (mean reduction 87 g, P=.16). After adjusting for confounding, results were similar. Conclusion: Fetal GSTT1 deletion significantly and specifically modifies the effect of smoking on gestational age-corrected birth weight.

AB - Objective: To assess whether functional maternal or fetal genotypes along well-characterized metabolic pathways (ie, CYP1A1, GSTT1, and CYP2A6) may account for varying associations with adverse outcomes among pregnant women who smoke. Methods: DNA samples from 502 smokers and their conceptuses, alongside women in a control group, were genotyped for known functional allelic variants of CYP1A1 (Ile462Val AA>AG/GG), GSTT1(del), and CYP2A6 (Lys160His T>A). Modification of the association between smoking and outcome by genotype was evaluated. Outcomes included birth weight, pregnancy loss, preterm birth, small for gestational age, and a composite outcome composed of the latter four components plus abruption. Results: No interaction between maternal or fetal genotype of any of the polymorphisms and smoking could be demonstrated. In contrast, the association of smoking with gestational age-adjusted birth weight (birth weight ratio) was modified by fetal GSTT1 genotype (P for interaction=.02). Fetuses with GSTT1(del) had a mean birth weight reduction among smokers of 262 g (P=.01), whereas in fetuses without the GSTT1(del) the effect of tobacco exposure was nonsignificant (mean reduction 87 g, P=.16). After adjusting for confounding, results were similar. Conclusion: Fetal GSTT1 deletion significantly and specifically modifies the effect of smoking on gestational age-corrected birth weight.

UR - http://www.scopus.com/inward/record.url?scp=77649113593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649113593&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e3181d06faf

DO - 10.1097/AOG.0b013e3181d06faf

M3 - Article

C2 - 20177288

AN - SCOPUS:77649113593

VL - 115

SP - 568

EP - 577

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -